TLR4 and primary ovarian failure: Conversely, ARNI treated groups showed lower levels of pulmonary TLR4 which is persistent with the results deduced by Khallaf et al (2023) in a previous research on cyclophosphamide-induced premature ovarian failure in rats (Khallaf et al. 2023).